Keyphrases
Insulin Resistance
100%
Rodents
100%
Healthy Volunteers
100%
HIV Protease Inhibitors
100%
Protease Inhibitor Resistance
100%
Protease Inhibitors
50%
Molecular Mechanism
33%
Relative Contribution
16%
Glucose Homeostasis
16%
Diabetes
16%
Clinical Efficacy
16%
Risk for Cardiovascular Diseases
16%
Oxidative Stress
16%
Type 1 Diabetes Mellitus (T1DM)
16%
Molecular Targets
16%
Recent Advances
16%
Clinical Application
16%
Adipokines
16%
Metabolic Changes
16%
Glucose Transporter 4 (GLUT4)
16%
SOCS1
16%
Relative Difference
16%
Pharmacokinetic Profile
16%
Cellular Mediators
16%
Overall Risk
16%
Individual Treatment Plan
16%
Plan-based
16%
Target Profile
16%
Proteosome
16%
Medicine and Dentistry
In Vitro
100%
Insulin Resistance
100%
Volunteer
100%
Human Immunodeficiency Virus Proteinase Inhibitor
100%
Proteinase Inhibitor
50%
Diabetes
16%
Cardiovascular Disease
16%
Mediator
16%
Oxidative Stress
16%
Adipocytokine
16%
Diabetes Mellitus
16%
Glucose Homeostasis
16%
Pharmacokinetics
16%
Glucose Transporter 4
16%
Suppressor of Cytokine Signaling 1
16%
Biochemistry, Genetics and Molecular Biology
Insulin Resistance
100%
Normal Human
100%
HIV Protease Inhibitor
100%
Protease Inhibitor
50%
Glucose Homeostasis
16%
Mediator
16%
Pharmacokinetics
16%
Oxidative Stress
16%
Adipokine
16%
Suppressor of Cytokine Signaling 1
16%
Glucose Transporter
16%
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Resistance
100%
Normal Human
100%
Human Immunodeficiency Virus Proteinase Inhibitor
100%
Proteinase Inhibitor
50%
Molecular Target
16%
Adipocytokine
16%
Glucose Transporter 4
16%
Diabetes Mellitus
16%
Suppressor of Cytokine Signaling 1
16%
Cardiovascular Disease
16%
Pharmacokinetics
16%